These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6462571

  • 41. Clonogenic cell assay for carcinoma of the lung.
    Kanzawa F, Hoshi A, Shimizu E, Saijo N, Miyazawa N, Shimabukuro Z.
    Gan; 1984 Jan; 75(1):81-8. PubMed ID: 6327452
    [Abstract] [Full Text] [Related]

  • 42. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J, Héron JF, Mayer F, Charrot-Chinet P, Toulouse C.
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [Abstract] [Full Text] [Related]

  • 43. Human tumor colony assay and chemosensitivity testing.
    Salmon SE.
    Cancer Treat Rep; 1984 Jan; 68(1):117-25. PubMed ID: 6692423
    [Abstract] [Full Text] [Related]

  • 44. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT, Sevin BU.
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Comparative study on the sensitivities of seven human cancer cell lines to rubescensine A].
    Li XT, Lin C, Li PY, Zhang TM.
    Yao Xue Xue Bao; 1985 Apr; 20(4):243-6. PubMed ID: 4072693
    [No Abstract] [Full Text] [Related]

  • 50. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T, Takeshima N, Nishida H, Hirai Y, Hasumi K.
    Anticancer Res; 2003 Apr; 23(3C):2885-90. PubMed ID: 12926129
    [Abstract] [Full Text] [Related]

  • 51. [Current status of the human tumor clonogenic assay for gastrointestinal cancer].
    Tanigawa N.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1588-92. PubMed ID: 4026328
    [Abstract] [Full Text] [Related]

  • 52. [An in vitro chemosensitivity study using human tumor clonogenic assay in urologic malignancies].
    Naito K, Hisazumi H, Asari T, Kobashi K, Amano T, Uchibayashi T.
    Hinyokika Kiyo; 1986 Dec; 32(12):1959-66. PubMed ID: 3825833
    [Abstract] [Full Text] [Related]

  • 53. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE, Cree IA, Kurbacher CM, Hartmann DM, Linder D, Harel G, Gleiberman I, Caruso PA, Ricks SH, Untch M.
    Cancer Res; 1995 Nov 15; 55(22):5276-82. PubMed ID: 7585588
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms.
    Weisenthal LM, Dill PL, Finklestein JZ, Duarte TE, Baker JA, Moran EM.
    Cancer Treat Rep; 1986 Nov 15; 70(11):1283-95. PubMed ID: 2429763
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG, Ciavattini A, Provinciali M, Di Stefano G, Lucarini G, Goteri G, Biagini G.
    Anticancer Res; 1996 Nov 15; 16(5B):3229-34. PubMed ID: 8920796
    [Abstract] [Full Text] [Related]

  • 58. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Kendrick JE, Straughn JM, Oliver PG, Wang W, Nan L, Grizzle WE, Stockard CR, Alvarez RD, Buchsbaum DJ.
    Gynecol Oncol; 2008 Mar 15; 108(3):591-7. PubMed ID: 18177927
    [Abstract] [Full Text] [Related]

  • 59. Activity of oxaliplatin against human tumor colony-forming units.
    Raymond E, Lawrence R, Izbicka E, Faivre S, Von Hoff DD.
    Clin Cancer Res; 1998 Apr 15; 4(4):1021-9. PubMed ID: 9563898
    [Abstract] [Full Text] [Related]

  • 60. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Van Le L, Waggoner S.
    Gynecol Oncol; 1998 Aug 15; 70(2):263-6. PubMed ID: 9740702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.